NCT02073097 2024-05-29Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell LymphomaCase Comprehensive Cancer CenterPhase 1/2 Completed48 enrolled 18 charts
NCT00061945 2022-05-03Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1/2 Completed302 enrolled 11 charts